NuVue Therapeutics, Inc.

Home

Company

Milestones

Technologies

Enhanced Ultrasound

Microencapsulation

Cryothermal Effects

Diagnostic Products

ColorMark-A Biopsy Needle

ColorMark-C Biopsy Needle

BrightMark Tissue Markers

Therapeutic Products

ChemoAblator

CryoChemoAblator

NuVue Chemo

Management

Roger Kolasinski

James Stuber

James Kulinski

Patrick Le Pivert

Dennis Morrison

Mark Ehlert

News

510(k) Approval Received

Best Life Sciences Co

Contact

Legal

Therapeutic Products














NuVue’s cancer therapeutics are designed to provide a robust
, targeted kill of tumors.  Using only 1/200 – 1/500 of a systemic dose, these products are intended to avoid the toxic side effects of standard chemotherapy, sparing the patient’s immune system and providing a better quality of life during and after therapy.  NuVue’s therapeutics will be capable of treating all soft tissue cancers.

NuVue Therapeutics, Inc.  Copyright 2011.  All rights reserved.

Website powered by Network Solutions®